LIVMARLI- maralixibat chloride solution United States - English - NLM (National Library of Medicine)

livmarli- maralixibat chloride solution

mirum pharmaceuticals inc. - maralixibat chloride (unii: v78m04f0xc) (maralixibat - unii:uyb6uof69l) - livmarli® is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 3 months of age and older. none. risk summary maternal use at the recommended clinical dose of livmarli is not expected to result in measurable fetal exposure because systemic absorption following oral administration is low [see clinical pharmacology (12.3)]. maralixibat may inhibit the absorption of fat-soluble vitamins [see warnings and precautions (5.3) and clinical considerations] . in animal reproduction studies, no developmental effects were observed (see data) . the estimated background risk of major birth defects for the indicated population is higher than the general population because alagille syndrome is an autosomal dominant condition. the estimated background risk of miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respec

LIVMARLI Israel - English - Ministry of Health

livmarli

neopharm (israel) 1996 ltd - maralixibat chloride - solution (oral) - maralixibat chloride 10 mg/ml - maralixibat chloride - livamrli ® is an ileal bile acid transporter (ibat) inhibitor indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 1 year of age and older.

Livmarli European Union - English - EMA (European Medicines Agency)

livmarli

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.

LIVMARLI SOLUTION Canada - English - Health Canada

livmarli solution

mirum pharmaceuticals, inc. - maralixibat (maralixibat chloride) - solution - 9.5mg - maralixibat (maralixibat chloride) 9.5mg

Dasatinib Clonmel 100 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

dasatinib clonmel 100 mg film-coated tablets

clonmel healthcare ltd - dasatinib - film-coated tablet - 100 milligram(s) - dasatinib

Dasatinib Clonmel 20 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

dasatinib clonmel 20 mg film-coated tablets

clonmel healthcare ltd - dasatinib - film-coated tablet - 20 milligram(s) - dasatinib

Dasatinib Clonmel 50 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

dasatinib clonmel 50 mg film-coated tablets

clonmel healthcare ltd - dasatinib - film-coated tablet - 50 milligram(s) - dasatinib

Dasatinib Clonmel 70 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

dasatinib clonmel 70 mg film-coated tablets

clonmel healthcare ltd - dasatinib - film-coated tablet - 70 milligram(s) - dasatinib

Letrozole Denk 2.5 tablets film-coated Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

letrozole denk 2.5 tablets film-coated

haupt pharma munster gmbh - letrozole - tablets film-coated - 2,5mg

Glimepiride Denk 3 tablets Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glimepiride denk 3 tablets

denk pharma gmbh & co. kg - glimepiride - tablets - 3mg